Effect of weekly administration of bevacizumab, gemcitabine, and oxaliplatin in patients with heavily pretreated ovarian cancer

被引：0
|
作者：
Ikeda, Yuji
Kikuchi, Yoshihiro
Takano, Masashi
Goto, Tomoko
Kouta, Hiroko
Sasaki, Naoki
Kudoh, Kazuya
Oda, Katsutoshi
Nagasaka, Tsuneki
Kita, Tsunekazu
机构：
[1] Ohki Mem Canc Ctr Women, Tokorozawa, Saitama, Japan
[2] Natl Def Med Coll, Tokorozawa, Saitama 359, Japan
[3] Nishisaitama Chuo Natl Hosp, Tokorozawa, Saitama, Japan
[4] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan
[5] Kawakita Gen Hosp, Dept Obstet & Gynecol, Tokyo, Japan
[6] Nara Prefectural Nara Hosp, Nara, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5037
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: A multicenter phase II study
    Kakolyris, S.
    Kalbakis, K.
    Potamianou, A.
    Malamos, N.
    Vamvakas, L.
    Christophillakis, C.
    Tselepatiotis, E.
    Giassas, S.
    Mavrousis, D.
    Amarantidis, K.
    Georgoulias, V.
    [J]. ONCOLOGY, 2006, 70 (04) : 273 - 279
  • [22] Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: A multicenter phase II study
    Kakolyris
    [J]. ONCOLOGY, 2006, 71 (3-4) : 203 - 203
  • [23] Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer
    Chollet, P
    Bensmaine, MA
    Brienza, S
    Deloche, C
    Cure, H
    Caillet, H
    Cvitkovic, E
    [J]. ANNALS OF ONCOLOGY, 1996, 7 (10) : 1065 - 1070
  • [24] The use of gemcitabine (G) in heavily pretreated breast cancer patients
    Valerio, M. R.
    Benfante, B.
    Scibilia, C.
    Spinnato, F.
    Cicero, G.
    Scaglione, D.
    Cocchiera, A.
    Amato, C.
    Cipolla, C.
    Graceffa, G.
    Russo, A.
    Fulfaro, F.
    D'Angelo, G.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 145 - 145
  • [25] Complete remission of patients with heavily pretreated uterine sarcomas by weekly bevacizumab and temozolomide.
    Takasaki, Kazuki
    Ikeda, Sayaka
    Matsuura, Hiroko
    Kudoh, Kazuya
    Yoshikawa, Tomoyuki
    Kouta, Hiroko
    Takano, Masashi
    Kikuchi, Ryoko
    Horikoshi, Miyuki
    Kikuchi, Yoshihiro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer
    O'Malley, David M.
    Richardson, Debra L.
    Rheaume, Patrick S.
    Salani, Ritu
    Eisenhauer, Eric L.
    McCann, Georgia A.
    Fowler, Jeffrey M.
    Copeland, Larry J.
    Cohn, David E.
    Backes, Floor J.
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 121 (02) : 269 - 272
  • [27] Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated, recurrent epithelial ovarian cancer
    Hurt, J.
    Backes, F.
    Rheaume, S.
    Richardson, D.
    Fowler, J.
    Copeland, L.
    Cohn, D.
    Eisenhauer, E.
    Salani, R.
    O'Malley, D.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S47 - S47
  • [28] Gemcitabine in heavily pretreated patients with recurrent ovarian, peritoneal and fallopian tube carcinoma
    Piura, B
    Rabinovich, A
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2004, 25 (04) : 449 - 452
  • [29] Bi-weekly oxaliplatin (OXA) and gemcitabine (GEM) in cisplatin pretreated patients with relapsed ovarian cancer (ROC): Preliminary data of a phase II trial
    Germano, D.
    Bilancia, D.
    Dinota, A.
    Romano, R.
    Rosati, G.
    Manzione, L.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 153 - 153
  • [30] Weekly paclitaxel in heavily pretreated ovarian cancer patients: does this treatment still provide further advantages?
    Miolo, GianMaria
    Bidoli, Ettore
    Lombardi, Davide
    Santeufemia, Davide Adriano
    Capobianco, Giampiero
    Dessole, Francesco
    Scalone, Simona
    Spazzapan, Simon
    Sorio, Roberto
    Tabaro, Gianna
    Veronesi, Andrea
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 285 (02) : 499 - 503
12345